A Phase III, Double-Blind, Randomized, Placebo-Controlle

Project: Research project

Description

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects with Painful Diabetic Peripheral Neuropathy
StatusActive
Effective start/end date3/1/168/31/19

Funding

  • ViroMed Co., Ltd.

Fingerprint

Diabetic Neuropathies
Peripheral Nervous System Diseases
Multicenter Studies
Placebos
Safety